Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Bull Exp Biol Med ; 172(3): 385-389, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35001303

RESUMEN

We conducted a comparative study of the calculated indices of insulin resistance HOMA-R, Caro, FGIR, and QUICKI in 29 healthy volunteers (mean age 26.21±0.93 years) with normal body mass index (23.34±0.55 kg/m2). Among the used methods for insulin resistance assessment, QUICKI is the only method that has characteristics required for the diagnostic criterium: low variability coefficient, 100% reproducibility, and minimum coefficient of variation.


Asunto(s)
Resistencia a la Insulina , Adulto , Glucemia , Humanos , Insulina , Reproducibilidad de los Resultados
2.
Bull Exp Biol Med ; 164(1): 10-14, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29124537

RESUMEN

A cross-sectional study of universe sample of patients (N=135; mean age -49.7±0.8 years) with metabolic syndrome yielded the incidence of cardiac autonomic neuropathy of 37.5%. The pathogenetic peculiarities were revealed for the onset and development of this neuropathy. At the early stages, the progress of cardiac autonomic neuropathy closely correlated with elevation of blood glucose, while endothelial dysfunction progressing at the later period against the background of persistent hyperglycemia is viewed as an extra factor contributing to the development of this disease.


Asunto(s)
Síndrome Metabólico/patología , Enfermedades del Sistema Nervioso Periférico/patología , Adulto , Sistema Nervioso Autónomo/patología , Sistema Nervioso Autónomo/fisiopatología , Glucemia , Estudios Transversales , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Enfermedades del Sistema Nervioso Periférico/sangre , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Factores de Riesgo , Volumen Sistólico
3.
Bull Exp Biol Med ; 162(1): 38-41, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27878727

RESUMEN

In a 3-month study, 30 obese patients were assigned to lifestyle modification therapy, which is the major component of all modern strategies correcting the metabolic syndrome. The 3-month course of non-pharmacological therapy significantly diminished the major index evaluating the state of these patients, i.e., the risk of cardiovascular disasters. This therapy positively affected all the states associated with metabolic syndrome: arterial BP attained the targets in 53% patients together with normalization of their nocturnal arterial BP dipping status; the lipid panel and carbohydrate metabolic indices normalized in 46 and 44% patients, respectively; hepatic steatosis moderated in 56% patients; and the disturbances in hemostasis were annihilated in 67% patients.


Asunto(s)
Restricción Calórica/métodos , Enfermedades Cardiovasculares/dietoterapia , Hígado Graso/dietoterapia , Síndrome Metabólico/dietoterapia , Obesidad/dietoterapia , Conducta de Reducción del Riesgo , Adulto , Glucemia/metabolismo , Presión Sanguínea , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/fisiopatología , Enfermedades Cardiovasculares/prevención & control , HDL-Colesterol/sangre , LDL-Colesterol/sangre , VLDL-Colesterol/sangre , Ejercicio Físico , Hígado Graso/sangre , Hígado Graso/fisiopatología , Humanos , Estilo de Vida , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Obesidad/sangre , Obesidad/fisiopatología , Estudios Prospectivos , Triglicéridos/sangre
4.
Bull Exp Biol Med ; 161(2): 237-40, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27383176

RESUMEN

ANS support of the cardiac work was assessed with analysis of heart rate variability in representative samples of patients with arterial hypertension and metabolic disturbances manifested by overweight, classes I-II obesity, compromised glucose tolerance, and type II diabetes. Initially enhanced sympathetic effects on the heart rate demonstrated no further increase during the orthostatic test in contrast to suprasegmentary influences enhanced by this test. The pronouncedness of revealed peculiarities in ANS drive to the heart correlated with metabolic disturbances, and these peculiarities attained maximum in patients with type II diabetes.


Asunto(s)
Sistema Nervioso Autónomo/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Hipertensión/fisiopatología , Obesidad/fisiopatología , Estudios Transversales , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Contracción Miocárdica
5.
Bull Exp Biol Med ; 160(1): 64-7, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26608375

RESUMEN

The role of JNK-mediated signal pathway and participation of p53 transcription factor in stimulation of realization of the growth potential of the mesenchymal precursor cells by alkaloid songorine were examined in vitro. Specific inhibitors of JNK and p53 enhanced stimulation of fibroblast colony/cluster formation and proliferative activity of mesenchymal precursor cells. Under these conditions, more pronounced effects were observed with early precursors of fibroblast CFU and in both cases were accompanied by a decrease in differentiation index of progenitor elements.


Asunto(s)
Alcaloides/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Células Madre Mesenquimatosas/efectos de los fármacos , Proteína p53 Supresora de Tumor/fisiología , Animales , Apoptosis/efectos de los fármacos , Benzotiazoles/farmacología , Células Cultivadas , Ensayo de Unidades Formadoras de Colonias , Proteínas Quinasas JNK Activadas por Mitógenos/antagonistas & inhibidores , Sistema de Señalización de MAP Quinasas/fisiología , Masculino , Células Madre Mesenquimatosas/metabolismo , Ratones , Ratones Endogámicos CBA , Inhibidores de Proteínas Quinasas/farmacología , Tolueno/análogos & derivados , Tolueno/farmacología , Proteína p53 Supresora de Tumor/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...